DAVIS, Calif.--(BUSINESS WIRE)--Jun. 23, 2015--
Arcadia Biosciences, Inc. (NASDAQ: RKDA), an agricultural technology
company, announced today that the US Food and Drug Administration (FDA)
has approved Arcadia’s application to amend relevant regulations to
permit the use of seed meal from the company’s high gamma-linolenic acid
(GLA) safflower seed in animal feed. The FDA concluded that the data
provided by Arcadia establishes the safety and utility of this safflower
meal for use in cattle and poultry feeds.
Arcadia’s GLA safflower seed is processed to produce nutritional oils
with more than 40 percent GLA. These oils are marketed by Arcadia under
the SONOVA® brand and are used in nutritional supplement
products for humans. GLA has multiple clinically-demonstrated
nutritional and medical benefits, including anti-inflammation, improved
skin condition and healthy weight management.
Seed meals are the ground residues obtained after processing seeds to
extract their oil and are common ingredients in livestock feed. This
approval provides an additional market for by-products from SONOVA GLA
safflower oil production.
“The FDA’s approval of Arcadia’s safflower meal in animal feed opens up
an entirely new market for us and improves the overall production
economics of GLA safflower oil,” said Eric Rey, president and CEO of
Arcadia Biosciences. “This approval, in addition to the recently
announced Argentinian approval for Stress-Tolerant Soybeans and
completion of the FDA Early Food Safety Evaluation of our Nitrogen Use
Efficiency trait, demonstrates Arcadia’s strong regulatory capabilities
and commitment toward creating the greatest possible value for our
entire trait portfolio.”
With this most recent FDA approval, Arcadia will immediately begin
marketing its safflower meal to animal feed manufacturers. The company
has been marketing GLA safflower oil under its SONOVA brand since 2010.
About Arcadia Biosciences, Inc.
Based in Davis, Calif., with additional facilities in Seattle, Wash. and
Phoenix, Ariz., Arcadia Biosciences (NASDAQ: RKDA) develops agricultural
products that create added value for farmers while benefitting the
environment and enhancing human health. Arcadia’s agronomic performance
traits, including Nitrogen Use Efficiency, Water Use Efficiency,
Salinity Tolerance, Heat Tolerance and Herbicide Tolerance, are all
aimed at making agricultural production more economically efficient and
environmentally sound. Arcadia’s nutrition traits and products are aimed
at creating healthier ingredients and whole foods with lower production
costs. The company was recently listed in the Global Cleantech 100 and
was previously named one of MIT Technology Review's 50 Smartest
Companies. For more information, visit www.arcadiabio.com.
Note Regarding Forward-Looking Statements
This press release contains forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995,
including statements relating to the company's GLA safflower oil and
meal products and the regulatory processes for such products.
Forward-looking statements are subject to risks and uncertainties that
could cause actual results to differ materially, and reported results
should not be considered as an indication of future performance. These
risks and uncertainties include, but are not limited to: the company and
its partners’ ability to develop and market commercial products
incorporating GLA safflower meal; the company’s compliance with laws and
regulations that impact the company’s business, and changes to such laws
and regulations; the company’s future capital requirements and ability
to satisfy its capital needs; and the other risks set forth in the
company's filings with the Securities and Exchange Commission from time
to time, including the risks set forth in Arcadia’s Registration
Statement on Form S-1 (including the final prospectus dated May 14,
2015) and other filings. These forward-looking statements speak only as
of the date hereof, and Arcadia disclaims any obligation to update these
forward-looking statements, except as required by law.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150623005586/en/
Source: Arcadia Biosciences, Inc.
Arcadia Biosciences, Inc.
Jeff Bergau, +1-312-217-0419